In this UCSF Medical Grand Rounds presentation (June 18, 2020), UCSF experts provide an update in treatments for COVID-19, with a particular focus on the new dexamethasone study. We also hear from two patients with persistent Covid symptoms, and discuss the epidemiology and science behind these so-called “long-haulers.” The session is hosted by UCSF Department of Medicine chair Bob Wachter.
Program
Bob Wachter: Introduction
00:03:13 – Sarah Doernberg, Associate Professor of Medicine, Division of Infectious Diseases – Updates in Therapies for Covid-19
00:20:35 – Q&A
00:30:27 – Followed by a Panel Discussion on Covid Patients with Persistent Symptoms:
• Timothy Henrich, Associate Professor of Medicine, Division of Experimental Medicine, ZSFG
• Coleen Kivlahan, Professor, Dept. of Family Community Medicine; Executive Medical Director of Primary Care Services at UCSF Health; Covid Patient
• Jeff Martin, Professor, Dept. of Epidemiology & Biostatistics
• Cliff Morrison, Former Clinical Nurse Manager, ZSFG; Covid Patient
• Michael Peluso, Clinical Fellow, Division of Infectious Diseases
01:16:53 – Bob Wachter: Closing
See previous Covid-19 Medical Grand Rounds:
• June 11: Covid-19: Update in Epidemiology, and, Are the Publication and FDA Approval Processes Moving Too Fast for Safety?
• June 4: The Covid-19 Pandemic in the Context of the Healthcare System, Economy, Race, Politics, Ethics, and History
• May 28: Update on Covid-19: Testing, ICU Practices and Outcomes at ZSFG, and the Experience of Elders in the Covid-19 Pandemic
• May 21: Update on Covid-19: Epidemiology, Treatments and Vaccines, Thromboembolic Complications, and the Multisystem Inflammatory Syndrome Affecting Children
See all UCSF Covid-19 grand rounds here:
